Cryo-Cell International Inc. (CCEL)
NYSE: CCEL · Services-Misc Health & Allied Services, NEC · Oldsmar, FL · filing with the SEC since 1997
Grade4.5
◀ Past 3.8● Present 5.0▶ Future 4.5
Who owns Cryo-Cell International Inc.
As filed with the SECHolders of 5% or more
1
Camac Partners, LLC holds 6.8% of Common Stock, as its SCHEDULE 13D/A filed Jul 7, 2026 says.
Directors and officers
6
report now, of 10 people on the record since 2006. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 1 named at left.
Holders of 5% or moreshare of the class, as filed
Camac Partners, LLC
SCHEDULE 13D/A · filed Jul 7, 2026 · Common Stock · 5.3% in Mar 25, 2026
CDMJ Nyberg Family Trust
SCHEDULE 13G · filed Dec 27, 2024 · Common Stock, par value $0.01 per share · reported falling below 5%
What CCEL reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Tianhe Stem Cell Biotechnologies Inc
A company bought · acquisition · owns, named in the 10-K filed Feb 27, 2026
Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Oct 28, 2025 to Oct 28, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2025 runs to Oct 28, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window
No one on the roster filed an open-market trade in the window.